Overweight Prevalence
Patients with personal or family history of medullary thyroid cancer should not use semaglutide
OSA, hyperlipidemia, CVD) Main exclusion criteria Diabetes HbA1c 6.5% Previous obesity surgery History of chronic pancreatitis Acute pancreatitis within 180 days Baseline characteristics Average age 46 years Female sex - 74% Average weight - 231 lbs (105 kg) Average BMI - 38 Randomized treatment groups Group 1 (1306 patients): Wegovy 2.4 mg subcutaneously once weekly Group 2 (655 patients): Placebo Wegovy was started at a dose of 0.25 mg once weekly and increased every 4 weeks over a period of 16 weeks to a target dose of 2.4 mg once weekly All patients also received diet and exercise counseling Coprimary endpoints were the percentage change in body weight from baseline to week 68 and achievement of a reduction in body weight of 5% or more from baseline to week 68 Primary outcome: Results In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight
This suggests that as the concentration of the medication increases in the body, the interaction with the peripheral nervous system becomes more pronounced
In 1998, the NIH lowered its standard a move that, according to a CNN article from the period, worried critics, as it stood to persuade doctors to start prescribing diet drugs for people who dont need them. While the new guideline brought the NIH in line with the World Health Organizations standards, the Newark Star-Ledger also reported, Eight of the nine members of the National Institutes of Health task force on prevention and treatment of obesity have ties to the weight loss industry. With a BMI of 27, I would have counted as normal in the 1980s and 1990s by many standards, rather than overweight
These findings reinforce that both are beneficial but with different focus areas: Wegovy for weight reduction and associated risks, Trulicity for blood sugar control and diabetes complications
